Morning Wrap

Today ’s Newsflow Equity Research 18 Dec 2020 08:51 GMT Upcoming Events Select headline to navigate to article

Hammerson Plan to list on Company Events

Morses Club 1H20 Results; remains profitable despite Covid-19 challenges Irish Lumbering to deal on Brexit over the weekend? UK Economic View November retail sales fall but outlook improves

Economic Events Ireland 22-Dec PPI Nov20 Wholesale Price Indsx Nov20

United Kingdom 18-Dec Retail Sales Nov20 22-Dec GDP Q3 Exports Q3 Imports Q3 Current Account Q3

United States

Europe

This document is intended for the sole use of Goodbody Investment Banking and its affiliates

Goodbody Capital Markets Equity Research +353 1 6419221 Equity Sales +353 1 6670222 Bloomberg GDSE

Goodbody Stockbrokers UC, trading as “Goodbody”, is regulated by the Central of Ireland. In the UK, Goodbody is authorised and subject to limited regulation by the Financial Conduct Authority. Goodbody is a member of and the Stock Exchange. Goodbody is a member of the FEXCO group of companies. For the attention of US clients of Goodbody Securities Inc, this third-party research report has been produced by our affiliate, Goodbody Stockbrokers Goodbody Morning Wrap

Hammerson Plan to list on Euronext Dublin

Hammerson announced this morning that it is to seek admission of its entire issued share Recommendation: Hold capital to the secondary listing segment of the Irish Stock Exchange (Euronext Dublin) and Closing Price: £0.26 to trading on the main market for listed securities of Euronext Dublin. Colm Lauder

+353-1-641 6042 Hammerson is seeking a secondary listing given the importance and scale of its investor base [email protected] and operations in continental Europe and Ireland. HMSO owns and manages prime retail property with a value of £1.2bn in France and £0.8bn in Ireland (Dundrum, Ilac, Pavillions) in addition to significant City Quarters development opportunities in Dublin (Dublin Central Site on O'Connell Street).

Alongside its directly managed portfolio, Hammerson also has exposure to Value Retail destinations outside of the UK including La Valleé in Paris and La Roca in Barcelona. Furthermore, as of the 23rd November 2020, around 27% of Hammerson's share capital held by institutional investors is held by investors based in the European Economic Area (excluding the UK).

A secondary listing on Euronext Dublin will enable Hammerson to maintain an efficient holding structure across its portfolio and guarantee an EU equivalent trading venue for Hammerson's shares. It is expected that Admission will become effective and that unconditional dealings in the Ordinary Shares on the Main Market will commence at 8.00am on 23rd December 2020.

Goodbody is acting as Sponsor to Hammerson plc in connection with the proposed admission to Euronext Dublin.

Home…

This document is intended for the sole use of Goodbody Investment Banking and its affiliates

Page 2 18 Dec. 20 Goodbody Morning Wrap

Morses Club 1H20 Results; remains profitable despite Covid-19 challenges

MCL published 1H20 results to end-August 2020 this morning. MCL had previously issued its Recommendation: Buy FY19 results only recently on the 27th of November, owing to a significant delay in its Closing Price: £0.44 reporting schedule. The 1H20 results show reduced gross loan growth -23% y/y, to be John Cronin expected given the difficult market conditions and the halt put in place on home collections +353-1-641 9187 at the start if the crisis in March. Customer numbers were down 25.7% to 205k. Adjusted [email protected] PBT came in at £2.3m, very close to our £2.4m forecast. Revenue was -24.3% y/y to £50.2m, driven by the challenges of lending to new and existing HCC customers and lower customer demand during lockdown. Impairments/revenues of 23.5%, is higher than last year’s 19% but it is comforting to note that it is still within of the 21-26% guidance range. Looking at costs, there was a decent beat, adjusted operating expenses (incl. agents commissions) came in c.£8m lower y/y (-15%) to £36.3m. Interest costs were £1.3m slightly lower than we expected as MCL with the current level of gearing still very low. The statement also notes an interim dividend of 1p and whilst below our 1.3p forecast, it is still a good outturn given the market backdrop.

Overall, this is a good set of numbers from MCL with the core home credit business performing much better than expected against the challenging backdrop of Covid- 19, remaining profitable. The integration of recent acquisitions is progressing well and will serve to boost returns in a medium-term context. MCL is in the early stages of its product diversification journey and while progress is slow, management mention that the acceleration towards digital working has benefited the group immensely, and the strategy to increase penetration of MCL’s customer base is a sensible one and should generate higher returns and better growth potential over time. The impact Covid-19 has had on the home credit market demonstrates the dangers of overreliance on one product and the continued investment in the digital business means MCL is well-placed to benefit from a Covid-19-related increase in market size.

Home…

This document is intended for the sole use of Goodbody Investment Banking and its affiliates

Page 3 18 Dec. 20 Goodbody Morning Wrap

Irish Banks Lumbering to deal on Brexit over the weekend?

So, Brexit looks like it’s coming down to fishing rights. There are a few issues on the table Eamonn Hughes still, but the gap is wide on fishing - accounting for a mere 0.1% of UK GDP and thereby +353-1-641 9442 putting the other 99.9% at risk! So, as the odds shorten on a deal, we thought it worth [email protected] recapping what that might be worth for the Irish banks. We think about this in the context Barry Egan largely of impairment, new lending activity (mainly SME) and cost of equity (COE). +353-1-641 6059 [email protected] For context on impairments, let’s take AIB which specifically modelled a failed EU/EU trade deal in its ECL disclosures in H1. In June, provisions were €2.44bn. AIB did a Downside

Scenario of Failed EU/UK trade talks (10% probability attached) whereby provisions would

rise to €2.74bn. So simply removing this scenario and adding the 10% probability back to the base case would reduce impairments by c.€30m, or about 7bps of CET1. It’s not transformational, compared with our €1.47bn full year charge, but it all helps. I suppose, you could argue that banks may feel better about SMEs, which may imply a better outturn.

Moving, to new lending, the “outperformer” in H2 was the mortgage market and all trends currently in approvals point to a strong start to 2021, Brexit deal or no deal. We note press reports this morning as well of legislation being put in place on a potential shared equity (30%) affordable housing plan, to come to market mid-2021. So, the main focus will be on SME lending. In the first instance, our new lending forecasts are premised on a negotiated trade deal, so in theory should show no change if we have a deal. However, we have to admit that updated forecasts in November were constructed with Brexit risk bubbling along in the background and evidence of very slow take-up in the government’s €2bn credit guarantee loan scheme. Indeed, the government yesterday indicated more than 15.3k closed or restricted businesses are seeking €110m in aid under a Covid support scheme launched following the October Budget. This might be a case of “chicken and egg” scenario, but a Brexit deal may have the potential to shift to a more positive bias on new lending activity in the SME and/or Corporate lending. Every additional €1bn of new lending (less funding cost) has the potential to add c.3.7% to FY22 pre-provision profit of AIB and c.3.0% to BOI.

Finally, we assign an 11.5% COE to our AIB core capital valuation and 12.5% for BOI (premium to reflect risk in its IT transformation plan). Thinking aloud, a Brexit deal (plus knowing we are on a trajectory of vaccine rollout) could argue for lowering our COE by 100- 150bps maybe. A key risk remains further lockdowns until the vaccines are widely available (I was in the city centre last Saturday afternoon and we are definitely going back into lockdown in January given the sheer crowds out and about, reinforced by the health officials comments yesterday evening), but every 100bps reduction in the COE would simplistically This document is intended for the sole use of Goodbody Investment Banking and its affiliates add c.8% to fair values, for some context.

Elsewhere, the Central Bank published its 3Q20 Arrears and Repossession stats yesterday. No surprises of note were evident, with all trends similar and positive on a yearly basis, continuing in a downward direction. The outstanding value of PDH mortgages is roughly flat (-0.4% y/y; -0.1% q/q) to €97.5bn, while total outstanding arrears has reached an all-time low of 9.7% of the balance (peak was 22.4% in Dec-12). We would expect this is inevitably the trough before metrics begin to tick upwards in 2021 post the pandemic. A very similar situation emerged for BTL mortgages, down 8.8% y/y (normal run-rate of contraction on a y/y is c.9-11%) to €15.9bn, while total outstanding arrears is at 24.8%.

On Brexit, maybe that’s just the way nations work, you need a proper firm deadline (31 December), so deals just happen to get done right at the end. Whilst our base case was always that a deal gets down, realistically, it probably has some positive impact on estimates and valuations once finally completed, hopefully.

Home…

Page 4 18 Dec. 20 Goodbody Morning Wrap

UK Economic View November retail sales fall but outlook improves

After rising consistently for the past six months, retail sales volumes in the UK fell by 3.8% Dermot O'Leary mom in November, compared to a forecasted fall of 4.2%, while the annual growth rate +353-1-641 9167 slowed to 2.4% yoy, from 5.8% in October. Excluding fuel, the annual rate came in at [email protected] +5.6% (+7.9% in October). Given their “essential” status, food sales was the only sector to see a monthly increase in volumes. As noted last month, internet sales continue to rise, aided greatly by the lockdown, and jumped 74.7% yoy. These now represent 31.4% of total sales. Even during a second national lockdown, with all non-essential retailers shutting their doors, retail sales are still remarkably 2.6% above the pre-Covid levels seen in February, especially when you consider that they were 12.9% below in May. The Christmas period will undoubtedly have had a big impact here as consumers sought to get out early. This theme will likely continue into the December figures, as pent-up demand gets released into the economy.

The rebound expected in December should even carry through to 2021 as consumer confidence grows sharply. According to one such survey by GfK this morning, confidence saw the largest increase in almost 8 years, jumping by 7 points to -26. The successful implementation of a vaccine distribution programme will have played a big part here. We are still far from out of the woods, with further lockdown measures likely, but at least the data is beginning to point in the right direction.

Home…

This document is intended for the sole use of Goodbody Investment Banking and its affiliates

Page 5 18 Dec. 20 Goodbody Morning Wrap

Issuer & Analyst Disclosures

Analyst Certification The named Research Analyst certifies that: (1) All of the views expressed in this research report accurately reflect my personal views about any and all of the subject securities and issuers. (2) No part of my remuneration was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by me in this report.

Regulatory Information Goodbody Stockbrokers UC, trading as Goodbody, is regulated by the Central . In the UK, is also subject to regulation by the Financial Conduct Authority. Goodbody is a member of Euronext Dublin and the London Stock Exchange. Goodbody is a member of the FEXCO group of companies. This publication has been approved by Goodbody. The information has been taken from sources we believe to be reliable, we do not guarantee their accuracy or completeness and any such information may be incomplete or condensed. All opinions and estimates constitute best judgement at the time of publication and are subject to change without notice. The information, tools and material presented in this document are provided to you for information purposes only and are not to be used or considered as an offer or the solicitation of an offer to sell or to buy or subscribe for securities.

Conflicts of Interest Goodbody has procedures and policies in place to identify and manage any potential conflicts of interest that arise in connection with its research business. Goodbody analysts and other staff who are involved in the preparation and dissemination of research operate and have a management reporting line that is independent to its business. Information barriers are in place between the Corporate Finance arm and the Research arm to ensure that any confidential and or price sensitive information is handled in an appropriate manner.

Our Investment Research Conflicts of Interest Policy is available at Conflicts of Interest

Investors should be aware, that, where appropriate, research may be disclosed to the issuer(s) in advance of publication, in order to correct factual inaccuracies only and not to materially amend the research in any way. Goodbody is satisfied that it has operational procedures in place, which ensure that such disclosures will not compromise the report’s objectivity.

Goodbody is acting as Corporate Broker and Rule 3 advisor to plc (the “Company”). Following the announcement of a possible cash offer for the Company, Goodbody will withhold any price target or recommendation until the conclusion of the Transaction.

Goodbody has provided investment banking services to AIB Group, Applegreen, , Bank of Ireland, , Collagen Solutions, Datalex, Draper Esprit, FBD Holdings, , First Derivatives, Grafton Group, Greencore, Harworth, Hibernia REIT, ICG, Kingspan, , Playtech, Rank Group, Supermarket Income REIT, and Yew Grove REIT in the past 12 months. Goodbody Stockbrokers acts as corporate broker to AIB Group, Applegreen, ARYZTA, Cairn Homes, Datalex, Draper Esprit, FBD Holdings, First Derivatives, Grafton Group, Greencore, Hibernia REIT, ICG, IPL Plastics, Kingspan, Origin Enterprises, Playtech, Rank Group, and Yew Grove REIT The list of companies for which Goodbody acts as market maker and on which it provides research, is available at Regulatory Disclosures

This document is intended for the sole use of Goodbody Investment Banking and its affiliates

Page 6 18 Dec. 20 Goodbody Morning Wrap

Other disclosures

We would like to inform you that Eamonn Hughes holds shares in AIB Group

A description of this company is available at Company Descriptions

All prices used in this report are as at close of business of the previous working day unless otherwise indicated.

A summary of our standard valuation methods are available at Valuation Methodologies

A summary of share price recommendations and whether material investment banking services have been provided to these companies is available at Regulatory Disclosures

Other important disclosures are available at Regulatory Disclosures

Goodbody updates its recommendations on a regular basis. A breakdown of all recommendations provided by Goodbody is available at Regulatory Disclosures Where Goodbody has provided investment banking services to an issuer, details of the proportion of buys, holds and sells attributed to that issuer will also be included. This is updated on a quarterly basis.

The date on which stock recommendations were first released for all stocks mentioned in this report are available at https://www.goodbody.ie/assets/Reg_Disclosures.pdf. If a different recommendation has been made in the previous twelve months, this will also be disclosed here.

Recommendation Definitions Goodbody uses the terms “Buy”, “Sell” and “Hold. The term “Buy” means that the analyst expects the security to appreciate in excess of 10% over a twelve month period. The term “Sell” means that the security is expected to decline in excess of 10% over the next twelve months. The term “Hold” means that the analyst expects the security to neither appreciate more than 10%, or depreciate more than 10% over the next twelve months.

On 26th November, 2012, the terms “Add” and “Reduce” were removed from the Recommendation Definitions and both were replaced with the “Hold” recommendation. Any Previous Recommendation that refers to either an “Add” means that the analyst expected the security to appreciate by up to 15% over a twelve month period. Any Previous Recommendation to “Reduce” means that the analyst expected the security to decline by up to 15% over the next twelve months.

In the event that a stock is delisted the firm will automatically cease coverage. If however the firm ceases to cover a stock for any other reason the firm will disclose this fact.

Distribution of research to clients of Goodbody Securities Inc (GSI) in the US

GSI distributes third-party research produced by its affiliate, Goodbody GSI is a member of FINRA and SIPC GSI does not act as a market-maker.

This information was current as of the last business day of the month preceding the date of the report. An affiliate of GSI may have acted, in the past 12 months, as lead manager/co-lead manager of a publicly disclosed offer of the securities in this company. Investors should be aware that an affiliate of GSI may have provided investment banking or non-investment-banking services to, and received compensation from this company in the past 12 months or may provide such services in the next three months. The term investment banking services includes acting as broker as well as the provision of corporate finance services, such as underwriting and managing or advising on a public offer. All transactions by US persons involving securities of companies discussed in this report are to be effected through GSI.

Disclaimer While all reasonable care has been taken in the production and dissemination of this report it is not to be relied upon in substitution for the

exercise of independent judgement. Nothing in this report constitutes investment, legal, accounting or tax advice, or a representation that This document is intended for the sole use of Goodbody Investment Banking and its affiliates any investment or strategy is suitable or appropriate to your individual circumstances, or otherwise constitutes a personal recommendation to you.

Private customers having access, should not act upon it in anyway but should consult with their independent professional advisors. The price, value and income of certain investments may rise or may be subject to sudden and large falls in value. You may not recover the total amount originally invested. Past performance should not be taken as an indication or guarantee of future performance; neither should simulated performance. The value of securities may be subject to exchange rate fluctuation that may have a positive or adverse effect on the price or income of such securities.

All material presented in this report, unless specifically indicated otherwise is copyright to Goodbody. None of the material, nor its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of Goodbody.

Goodbody, Ballsbridge Park, Ballsbridge, Dublin 4, Ireland T (+353 1) 6670400 W www.goodbody.ie E [email protected] Page 7 18 Dec. 20